Related Experiment Videos
Utility values and age-related macular degeneration
G C Brown1, S Sharma, M M Brown
1Retina Vascular Unit, Wills Eye Hospital, Jefferson Medical College, Philadelphia, PA, USA. gary0514@aol.com
Archives of Ophthalmology (Chicago, Ill. : 1960)
|January 15, 2000
Summary
Age-related macular degeneration significantly lowers patient utility values, with greater vision loss leading to a more substantial decrease. Patients with severe vision impairment were willing to trade a larger portion of their life for improved sight.
Area of Science:
- Ophthalmology
- Health Economics
- Quality of Life Research
Background:
- Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults.
- Understanding the impact of AMD on patient well-being is crucial for healthcare decision-making.
Purpose of the Study:
- To quantify the utility values associated with age-related macular degeneration (AMD).
- To assess how varying degrees of visual loss impact these utility values.
Main Methods:
- A cross-sectional study involving 80 patients with AMD and visual loss.
- Utility values were measured using the time trade-off and standard gamble methods.
- Patients were grouped based on visual acuity in the better-seeing eye.
Main Results:
- The mean utility value for AMD patients was 0.72 (time trade-off) and 0.81 (standard gamble).
- Utility values decreased significantly with increasing visual impairment, ranging from 0.89 (near-perfect vision) to 0.40 (light perception).
- Patients with severe vision loss were willing to trade a substantial portion of their remaining lifetime for improved vision.
Conclusions:
- Age-related macular degeneration substantially reduces patient utility values.
- The degree of visual loss in the better-seeing eye is a key determinant of these utility values.